SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001654954-19-003927
Filing Date
2019-04-02
Accepted
2019-04-02 08:56:59
Documents
3

Document Format Files

Seq Description Document Type Size
1 424B5 azrx424b5_apr2019.htm 424B5 444738
2 IMAGE ac_logo.jpg GRAPHIC 9744
3 IMAGE azurrx_logo000.jpg GRAPHIC 5760
  Complete submission text file 0001654954-19-003927.txt   467425
Mailing Address 760 PARKSIDE AVENUE SUITE 304 BROOKLYN NY 11226
Business Address 760 PARKSIDE AVENUE SUITE 304 BROOKLYN NY 11226 646-699-7855
AzurRx BioPharma, Inc. (Filer) CIK: 0001604191 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE
Type: 424B5 | Act: 33 | File No.: 333-226065 | Film No.: 19722903
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1